| Erica Danielle Bowles, MA, CCC-SLP | |
|
1451 Deerwood Dr, Jackson, MO 63755-4147 | |
| (573) 576-1456 | |
| Not Available |
| Full Name | Erica Danielle Bowles |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1451 Deerwood Dr, Jackson, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326689183 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2018030504 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erica Danielle Bowles, MA, CCC-SLP 1451 Deerwood Dr, Jackson, MO 63755-4147 Ph: (573) 576-1456 | Erica Danielle Bowles, MA, CCC-SLP 1451 Deerwood Dr, Jackson, MO 63755-4147 Ph: (573) 576-1456 |
News Archive
A new government report has shown that the use of electronic cigarettes has tripled among American high school students between 2013 and 2014, raising concerns that the fight against teen smoking is failing...
Research to develop a narrow-spectrum antibiotic that can target a particular species of bacteria without harming the other "good" bacteria present was described at the Society for General Microbiology meeting at Harrogate today (Thursday April 2).
The prestigious Janssen Industry Excellence Awards were announced as part of the official opening reception for the AusBiotech 2013 Conference at Brisbane City Hall last night; among them, internationally-acclaimed Brisbane-based researcher, Professor Ian Frazer.
A new study has identified an early vulnerability brain marker for psychosis. A research team led by University of Montreal and Sainte-Justine University Hospital Research Center shows that an exaggerated emotional response from the brain to non-threatening and non-emotional cues predicts the emergence of the first signs of psychotic symptoms in late adolescence.
Isis Pharmaceuticals, Inc. announced today that it has added a new drug, ISIS-APOCIIIRx, to its development pipeline. ISIS-APOCIIIRx provides a novel approach to treat hypertriglyceridemia, or high levels of triglycerides (TG).
› Verified 6 days ago
Dr. Carol Sue Ludwig, PHD CCC SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 215 West Main, Jackson, MO 63755 Phone: 573-204-0490 Fax: 573-204-0009 | |
Lori Obermann, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 614 E Adams St, Jackson, MO 63755 Phone: 573-243-9599 | |
Cassandra Bollinger, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 614 E Adams St, Jackson, MO 63755 Phone: 573-243-9501 | |
Mr. Jake Ryan Partridge, M.S. SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21257 Hwy 177, Jackson, MO 63755 Phone: 618-599-8558 | |
Molly Miller, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 614 E Adams St, Jackson, MO 63755 Phone: 573-243-9501 | |
Rachelle Elisabeth Brosnan, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 614 E Adams St, Jackson, MO 63755 Phone: 573-243-9501 | |
Alison Brooke Theobald, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 614 E Adams St, Jackson, MO 63755 Phone: 573-243-9513 |